Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
8.92 +0.24 / +2.76%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.92 0.00 / 0.00%
Volume: 1.2K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-7.4M-17.4M-18.7M-56.7M
Total Other Cash Flow1.2M5.1M6.0M20.8M
Funds From Operations-5.3M-9.7M-11.3M-34.4M
Funds From/For Other Operating Expenses9.7M-983.0K17.0M5.1M
Net Cash Flow - Operating Activities-15.1M-8.7M-28.3M-39.5M
InvestingIncrease In Investments-50.7M-62.0M-72.0M-113.4M
Decrease In Investments54.6M33.1M32.0M85.4M
Capital Expenditures-467.0K-1.2M-800.0K-1.1M
Net Cash Flow Investing3.3M-30.4M-40.9M-29.2M
FinancingShort Term Borrowings0.
Long Term Borrowings0.005.0M0.000.00
Long Term Debt Reduction-412.0K-445.0K-100.0K-142.0K
Net Proceeds Stock Sale58.0K65.9M46.6M88.4M
Common Preferred Redeemed--
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing-354.0K70.5M46.5M88.2M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash-12.1M31.4M-22.7M19.5M

To view my watchlist

Not a member yet?

Sign up now for a free account